Results for category "Surgeons"

Dr. Mark Holterman Bets Largely on Regenerative Medicine through Mesenchymal Stem Cells

Dr. Mark Holterman, a leading Pediatric Surgeon and professor at College of Medicine – University of Illinois, bets on regenerative medicine and collaborates with mesenchymal stem cells research and development. He collaborates with Sunshine Foundation, a non-profit foundation working on regenerative and cellular therapies. Interestingly, the foundation was set up after three young patients received highly effective regenerative therapies from a biotechnology firm known as Celltex Therapeutics. Interestingly, one among them received treatment for dysautonomia and systemic juvenile idiopathic arthritis. Read more about Dr. Mark Holterman at Health Grove.

It should be noted that Celltex Therapeutics uses mesenchymal stem cells for its cellular therapy. Dr. Mark Holterman says that MSCs can be isolated from the human body easily since it is available in abundance. He says that Fat tissue acts as the principal source of MSCs, but sometimes, the cells are taken from umbilical cord blood, bone marrow, and placenta tissues as well. Dr. Mark Holterman says that the MSCs have the capacity to develop into multiple cell types such as muscle cells, bone cells, and more. It can also work against inflammation, stop cellular decay, improve healing, and develop new blood vessels.

Dr. Mark Holterman also reiterates the benefits of fetal stem cells, especially for parents who faced miscarriage. He says that U.S. National Library of Medicine presented an article that details how fetal stem cells are significant in investigating various aspects of cell biology. It helps in the cell transplantation and ex vivo gene therapy. Dr. Mark Holterman confirms that embryonic stem cells are less ethically contentious and offers greater differentiation potential compared to adult stem cells. Visit to know more.

As a researcher and physician with nearly three decades of experience, Dr. Mark Holterman has deep expertise in basic science research and clinical medicine. He started his career at the University of Virginia as a Resident in general surgery and collaborated with a number of medical institutes in the later part of his career.

Dr. Mark Holterman is also the founder and Chief Executive of Mariam Global Health, a biotechnology investment management firm. He completed his graduation from Yale University in Biology and secured his M.D. and Ph.D. in Medicine and Immunology from the University of Virginia.